Bayer HealthCare - Pritor/Kinzal - Hypertension

Guidelines & Classification

Hypertension is one of the conditions for which disease-specific guidelines have been generated by different organisations.

Current evidence from different trials recommends that systolic blood pressure (SBP) needs to be lowered below 140mmHg, and diastolic blood pressure (DBP) below 90mmHg [1]. However, decisions about the management of hypertension should not only consider the blood pressure, but also the presence of additional risk factors, target organ damage (TOD) and other associated clinical conditions (ACC), such as diabetes. In 2003, the International Society of Hy-pertension Writing Group of the World Health Organization (WHO) as well as the European Soci-ety of Hypertension (ESH)-European Society of Cardiology (ESC) have issued guidelines on the management of hypertension to take into account all other related risk factors.
Risk stratification is important to determine the risk of hypertensive patients. Therefore, adults with a systolic blood pressure range (SBP) between 140 ? 159 mmHg are:

at low risk with no other risk factors

at medium risk with 1or 2 risk factors

at high risk with 3 or more risk factors, or TOD, or ACC [2]

References:

[1] Mancia G, et al. 2007 Guidelines for the Management of Arterial Hypertension The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) J Hypertens2007;25:1105-87.
[2] World Health Organization, International Society of Hypertension Writing Group. 2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension. J Hypertens 2003;21:1983-92.